Jounce Therapeutics, Inc. 4
4 · Jounce Therapeutics, Inc. · Filed Feb 2, 2017
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Purchase
Common Stock
2017-02-01$16.00/sh+6,700$107,200→ 27,025 total
4 · Jounce Therapeutics, Inc. · Filed Feb 2, 2017
Common Stock